Objective To evaluate the safety and durability of telitacicept treatment in patients with SLE by identifying the reasons for ...

Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, ...

JAXA samples reveal that asteroid Ryugu has a complete set of nucleobases, the building blocks of DNA.

U.S. Defense Secretary Lloyd Austin stated that American objectives in Iran are proceeding as planned and remain on target, ...

T. Rowe Price and Oak Hill Advisors ('OHA') today announced the launch of the T. Rowe Price OHA Flexible Credit Income Fund ('OFLEX' or 'the Fund'), a multi-strategy credit interval fund that can ...